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A failure in the compensate proliferation of pan-
creatic//-cells, as the primary pathogenic event, has
been reported in OLETF rat, a model of NIDDM.
The aim of the present study is to define whether
the/J-cell defect is attributed to the fetal stage islet
development, if so, whether the defect involves
down regulation of PDX-1 protein expression. Mor-
phological changes, //-cell function, and the
expression of PDX-1 protein were examined in the
cultured fetal islet-like cell clusters (ICCs) from
OLETF rats along with their diabetes-resistant
control counterpart LETO rats in the presence of
5.5 or 11.1mM glucose for 48, 72, 96, and 120-hr,
respectively. We have observed four abnormalities
in the ICCs of OLETF rats. First, a defective mor-
phogenesis was noted during the 72 to 120-hr
ICC culture, a period characterized by a dramatic
increase in both/J-cell and non-//-cell (a,/, and PP)
populations in control rats. This defective morpho-
genesis was demonstrated by a growth retardation
of epithelial stratification and poor development
of both //-cell and non-//-cell masses along with a
parallel decline in relevant islet hormone contents.
Second, a functional defect was characterized by
failure to response to glucose during the 96 to 120-
hr-cultured ICCs. Third, the ultrastructural analysis
revealed a significant reduction in the number
of secretory granules. Four, Western blot analysis
showed a significant decrease of PDX-1 protein ex-
pression in the OLETF ICCs cultured in 11.1mM
glucose for 48 to 72-hr and in 5.5mM glucose for
120-hr. Therefore, we concluded that during the
fetal stage of islet development, OLETF rats exhibit
both morphological and functional defects.
Keywords: OLETF rat; NIDDM; PDX-1; GSIS; Fetal ICCs;
Morphogenesis
Abbreviations: ICCs, Islet-like cell clusters; E17, 17 day
embryo; PBS, phosphate-buffered saline; IRI, radioimmu-
noassay of insulin immunoreactivity; IRG, glucagon immu-
noreactivity; GSIS, glucose-stimulated insulin secretion;
KRBB, Krebs-Ringer bicarbonate buffer
INTRODUCTION
Evidence has shown that insulin resistance is a
prerequisite for states of glucose intolerance to
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develop significant fasting hyperglycemia, but
clinical diabetes does not develop until pancrea-
tic fl-cells are no longer able to compensate
or insufficiently compensate for the abnormal
metabolic demand for insulin. [1-4] This suggests
that diabetes mellitus represent a failure in
the adaptation of pancreatic fl-cell renewal and
growth. Furthermore, morphorgenic studies
have shown that pancreatic fl-cells were origi-
nated from the growth and differentiation of
pancreatic stem cells of duct. During the period
of E17 to birth, an accelerated growth of islet cell
populations is evident by both an elevated level
of cell proliferation and the presence of large
aggregated ductal epithelial cells, which subse-
quently differentiated into specific islet cell
populations.
5-7] These processes are closely cor-
related with the transcriptional regulation of
cell-specific gene expression. 8
Otsuka Long-Evans Tokushima Fatty (OLETF)
rats develop glucose intolerance with hyperin-
sulinemia at adulthood. 9 In earlier studies, we
have shown that insulin resistance was apparent
at 12 weeks of age, 101 prior to the impairment of
pancreatic fl-cell function. 111 Furthermore, the
pancreatic /3-cells of OLETF rats failed to com-
pensate for a higher rate of fl-cell prolifera-
tion by a partially pancreatectomy procedure as
compared to the control rats. 121 The results
implied that the pancreatic fl-cells of OLETF
rats were unable to compensate for changes in
functional demand, once diabetogenic factors
were sustained. However, it is unclear whether
the islet cell defects in the OLETF rats are
originated in a failure at the fetal stage. If so,
whether a homeodomain-containing transcrip-
tion factor, PDX-1, is associated with the defect
in islet cell development since PDX-1 plays an
essential role in the regulation of morphogenesis
of pancreatic epithelium and the progression
of endocrine cell differentiation. 13-161 To test
this hypothesis, we investigate the differences in
morphogenesis, functional role, and the PDX-1
expression level in the cultured fetal islet-like
cell clusters (ICCs) from OLETF rats and their
diabetes-resistant counterparts,
Tokushima Otsuka (LETO) rats.
[17]
Long-Evans
MATERIALS AND METHODS
Animals
The OLETF rats and their control counterpart
LETO rats (four weeks of age) were obtained
from the Tokushima Research Institute, Otsuka
Pharmaceutical Company. The animals were
maintained in our animal facility under specific
pathogen-free condition (Institute of Animal
Experimentation, Tokushima University) until
the age of 12 weeks for mating. All the studies
were conducted with primiparous pregnancy
rat. Pregnancy was timed from day 0 begin-
ning in the morning when vaginal smears were
monitored for the first presence of sperm. The
non-fasting blood glucose and insulin levels
were measured weekly at 4-5 p.m. after preg-
nancy. The animals were fed with standard
rat chow (Oriental Yeast, Tokyo, Japan) and
tap water ad libitum. The temperature (21 4-
2C), humidity (55 4- 5C), and lighting (07 00-
19:00) were strictly controlled.
Preparation and Culture of Fetal
Islet-like Cell Clusters (ICCs)
On day 21 of gestation, pregnant rats were
sacrificed by cervical dislocation after anesthe-
tized with ether and the fetuses were rapid-
ly removed. The fetal pancreases were finely
minced and transferred to glass vials containing
4ml of Hank’s balanced salt solution with 2mg/
ml collagenase (S-1, Nitta Gelatin, Tokyo, Japan).
The tissue fragments were shaken rapidly at
37C and digested for approximately 2min.
The digest was then plated on a 60mm petri
dish (Steriline, Teddington, UK) to allow cells to
attach to the plate. The cells were cultured at
37C in a humidified atmosphere of 5% CO2
in ambient air in Dulbecco’s Modified EagleDEFECTIVE MORPHORGENESIS OF FETAL ICCs 291
Medium supplemented with 10% fetal bovine
serum (Laboratories, Logan, UT), 100U/ml
benzylpenicillin and 0.1mg/ml streptomycin
for the first 24hr. At this time the culture
medium was changed to RPMI-1640 medium
containing the same supplements as above. Vari-
ous concentrations of glucose were added
at the beginning of culture and maintained until
the end of each experimental time point. Over
a period of 48-hr, three-dimensional cell aggre-
gates were formed and referred to as ICCs. The
ICCs consist predominantly of epithelial cells
and a limited number of cells expressing islet
hormones. The ICCs were harvested at 48-hr and
cultured with fresh medium daily for 72, 96, and
120-hr, respectively.
Hormone Content
A group of 10 ICCs were pooled, washed twice
with PBS, resuspended in 200tl of distilled
water, and homogenized by sonication. The
DNA content of a 50 tl aliquot of the homo-
genate was measured by fluorophotometry
using a calf thymus DNA (Sigma) as standard.
The remainder of the homogenate was mixed
with 300 tl of cold-acidified ethanol (0.18M HC1
in 95% ethanol) for an overnight extraction at
4C. After centrifugation at 3000 rpm for 30 min,
the supernatant was dried down and stored at
-20C for radioimmunoassay of insulin immu-
noreactivity (RIA) and glucagon immunoreac-
tivity (IRG).
Glucose-stimulated Insulin
Secretion (GSIS)
Insulin secretion was measured for a group of 10
pooled ICCs in a transwell (New TranswellTM-
Clear, Costar Scientific Corporation Cambridge,
MA). The ICCs were preincubated in l ml
of Krebs-Ringer bicarbonate buffer (KRBB)
containing 143.5mM Na +, 5.8mM K +, 2.5mM
Ca2+, and 25 mM CO-, 0.3% bovine serum
albumin (BSA, Fraction V, ICN, Lisle, IL) and
3.3mM glucose at 37C, in an atmosphere of
95% 02 5co CO2 for 30 min. After preincubation,
transwells containing ICCs were incubated
for 2hr in I ml KRBB. During the 1st hour,
the medium was supplemented with 3.3mM
glucose. Subsequently, the transwell was
transferred to a medium containing 27.7mM
glucose for the 2nd hour incubation. At the
end of the incubations, aliquots were removed
and stored at -20C for IRI assay. The remain-
ing ICCs were subjected to DNA content analy-
ses using the same procedure as described above.
In all cases, duplicates were performed for
each experimental condition.
Analytical Methods
Blood glucose values were determined by a
glucose oxidase method (Toecho Super, Kyoto
Daiichi Kagaku, Kyoto, Japan). IRI was deter-
mined using a commercially available IRI kit
(Eiken Kagaku Co., Tokyo, Japan) with rat in-
sulin (Novo Nordisk A/S, Bagsvaerd, Den-
mark) as a standard. IRG was measured using
antiserum OAL-123 (Otsuka Pharmaceutical,
Tokushima, Japan) that recognizes the free C-
terminal end of glucagon but not glicentin or
oxyntomodulin.
[19]
Western Blot Analysis
ICCs were prepared as described above and
washed twice with PBS. The ICC pellet was
homogenized by sonication in lysis buffer. After
centrifugation at 15,000rpm for 15min, the
supernatant was frozen. The protein concentra-
tion was determined using a micro BCA protein
assay kit (PIERCE, Rockford, IL) with albu-
min as a standard (PIERCE, Rockford, IL). Ten
microgram of proteins were separated by a
10% SDS-PAGE and transferred to a nitrocellu-
lose membrane. The nitrocellulose membrane
was blocked with 3% BSA in PBS for 90mins
and incubated at 4C overnight in TBS buf-
fer (20mM Tris-HC1, 150mM NaC1, pH7.4)292 M. ZHU et al.
containing a 1:5000 dilution of anti-PDX-1 anti-
serum. The PDX-1 antibody was generated by
immunizing a rabbit with a synthetic peptide
269SPQPSSIAPLRPQE282. I201 The blot was
washed three times in TBS with 0.1% Tween-20
(TBS-T). The membrane was then incubated for
60min at room temperature in TBS containing
a 1:5000 dilution of a donkey anti-rabbit IgG
horseradish peroxidase antibody (Amersham,
International plc, Buckinghamshire, England).
After three 30min washes with TBS-T, immu-
noreactive bands were visualized by incuba-
tion with luminol (ECL (R) Western blotting Kit;
Amersham, Tokyo, Japan). Quantification was
achieved by densitometric scanning.
Immunostaining
The ICCs were fixed in 10% buffered formalin
for 25 min and then embedded in paraffin fol-
lowing a standard protocol. Two sets of three
serial sections (3-5 tm thick) were obtained at
an interval of 250 tm. Sections were immunos-
tained using commercial ABC kits (Vector
Laboratories Inc. Burlingame, CA). The primary
antibodies used were polyclonal guinea pig anti-
porcine insulin antibody (1:400, Dako Carpin-
teria, CA) and a mixture of antibodies against
glucagon (rabbit anti-porcine glucagon, 1:1000,
Dako Carpinteria, CA), somatostatin (rabbit anti-
synthetic somatostatin, 1:2000, Monosan
Synbio, The Netherlands) and pancreatic poly-
peptide (rabbit anti-bovine pancreas poly-
peptide, 1:4000, Monosan Synbio, The
Netherlands). Afterwards, the sections were
visualized by either 3,3t-diaminobenzidine or
alkaline phosphatase substrate (Vector RedTM,
Vector Laboratories Inc. Burlingame, CA).
Methyl green staining was used to reveal the
duct-like structure or epithelial stratification.
The profile area of either fl-cell or non-fl-cell
mass, as a percentage of the total ICCs profile
area, was quantified at an original magnification
of 400x on a monitor screen using an Olympus
microscope connected to a color video camera
and an image analysis system. The images
were calibrated using images of a stage micro-
meter taken at the appropriate magnifications.
A total of 30-40 ICCs (profile area 2500m2)
were measured for each time period in the
experiments.
Electron Microscopy
For electron microscopy, the ICCs were fixed in
2.5% (vol/vol) glutaraldehyde dissolved in PBS
(pH 7.2) for 2 hr at 4C, and postfixed with 1%
OsO4. After dehydration, specimens were em-
bedded in Epon 812. Ultrathin sections were
prepared by mounting on one-hole grids and
stained with uranyl acetate followed by lead
citrate. Examination was preformed on a TEM
HITACHI 7000 at an accelerating voltage of
60 kV.
Statistical Analyses
Results were expressed as means + SEM. For
relative fl-cell mass (%) and non-fl-cell mass (%),
a 10% adjusted means + SEM was presented
since the distribution of variables was skewed.
Statistical significance was determined using
either the Student’s t-test (paired or unpaired)
or analysis of variance (ANOVA). The level
of significance was set at P 0.05. All data
were analyzed with a Macintosh SPSS(R) software
package, version 6.0 (SPSS Inc., Chicago, IL).
RESULTS
In Vivo Metabolic State of OLETF
and LETO Rats During Pregnancy
In order to ascertain that the fetal pancreas
development was not affected by maternal
hyperglycemia during pregnancy,we have meas-
ured the fasting blood glucose and plasma
insulin level during the period of pregnancy
(Tab. I). No significant difference of bloodDEFECTIVE MORPHORGENESIS OF FETAL ICCs 293
TABLE Non-fasting blood glucose and plasma insulin of
OLETF and LETO rats during the pregnancy
Glucose Insulin
Pregnancy (mM) (pM)
OLETF (n 10)
lwk 7.7 4- 0.2 350.7 4- 53.3
2wk 5.4 4- 0.2 310.2 4- 30.5
3wk 5.8 4- 0.4 298.1 4- 47.4
LETO (n 10)
lwk 7.3 4- 0.1 349.7 4- 60.7
2wk 5.9 4- 0.3 301.1 4- 20.5
3wk 4.7 4- 0.3 299.1 4- 57.4
Data presented as means 4- SEM. No significant difference
in non-fasting blood glucose and plasma insulin of OLETF
and LETO rats were found during the pregnancy.
glucose and plasma insulin level was found
between the OLETF and LETO rats suggest-
ing that fetal pancreas development was under
normoglycemic condition.
Morphological Development
of Fetal ICCs
The fetal ICCs cultured in a medium containing
5.5mM glucose showed no dramatic differences
in the number, size, and shape between the
OLETF and LETO during 48 to 96-hr culture.
However, when the glucose concentration in
the medium was increased to 11.1 mM, an out-
growth of islet was observed at 72-hr of the
ICCs from LETO rats and the number of cell
clusters (< 100m in diameter) increased with
culture time. In contrast, the ICCs from OLETF
rats remain rounded, enlarged and regular
shaped.
As shown in Figure 1, three distinct patterns
of morphological development were observed in
the LETO ICCs cultured in 11.1mM glucose.
First, for the 48- to 72-hr culture (1-A and l-B),
large aggregated epithelial cells were evident in
some cell clusters and positive islet hormone
staining was observed for either a single cells or
for a small groups of positive cells, which were
scattered within the epithelium. The hormone-
expressing cells were found to gather as small
FIGURE 1 Morphological development of fetal ICCs cul-
tured in the presence of 11.1mM glucose. Immunostaining
was performed by ABC method, fl-cells were stained in red
and non-fl-cells (c, 6, and PP) were stained in brown. Methyl
green staining shows the epithelial structure. A to H re-
present the ICCs from LETO rats and to show the ICCs
from OLETF rats. Different culture times were shown as,
72h-cultured ICCs: A (100X), and B (400X); 96h-cultured
ICCs: C (100X) and D (400X); 120h-cultured ICCs: E (100X), F
(400X), G (400X), H (400X), (100X), and J(100X). Electron
photomicrographs are shown in K (5000X, LETO ICCs
cultured for 120-hrs) and L (5000X, OLETF ICCs cultured
for 120-hrs). (See Color Plate I).
cell groups that appeared to be budding out
from the ICCs without any well-defined islet cell
architecture. However, the epithelial structure
showed marked variations between different
ICCs. Second, for the 72- to 96-hr culture, some
of the ICCs showed epithelial stratification with
a portion of the cells arranged in a duct-like
structure (1-C). Immunostaining for islet hor-
mones demonstrated insulin-positive (l-D) and
non-fl-cell hormone-positive cells (not shown)
scattered in duct-like structured cells. In addi-
tion, the hormone-positive cell outgrowths were
more commonly encountered in the peripheral
portion of the ICCs. Third, for the 96-to 120-hr
culture (1-E and l-F), typical isl,ts were formed,
budding out from the ICCs, consisting of fl-cells294 M. ZHU et al.
and the peripheral distribution of non-fl-cells (1-
G and l-H). Since the aggregated epithelial cells,
duct-like structure, and typical islets budding
out from the ICCs appear in some of the clusters
at the same culture time, it is unclear whether
these three patterns represent three consecutive
steps in the development of ICCs in vitro. Based
upon our observation, it is clear that these
three patterns of morphological development
are influenced by the glucose concentration
in culture medium. The morphological develop-
ment of the ICCs cultured in 5.5mM glucose,
such as fl-cell mass, epithelium growth, and islet
budding, appears to be slower than those of
the ICCs cultured in 11.1mM glucose (data not
shown). In contrast to the LETO ICCs, three
dramatic differences were evident in ICCs from
the OLETF rats (1-I and l-J), including retard-
ed epithelium growth, a lower number of islet
hormone-positive cells, and rarely observed islet
budding out from the ICCs. Upon further ex-
amination of ultrastructure of ICCs using
electron microscope, a striking reduction in the
number of secretory granules was found in
the OLETF ICCs (l-L), in contrast to the LETO
counterpart (l-K).
We also examined the hormone contents and
islet cell masses in ICCs. Figure 2 shows the
changes in insulin and glucagon contents in ICC
extracts as the absolute values relative to the
corresponding DNA content. For 5.5mM glu-
cose culture, the insulin content in the LETO
ICCs appeared to be higher than those of the
OLETF ICCs (2-A). Similarly, the glucagon con-
tent in the LETO ICCs was higher at each
experimental point than those of the OLETF
counterparts. However, the extent was not
significant because of the large individual vari-
ations (2-C). In contrast, the 11.1mM glucose
culture has a significant increase in insulin
content (2-B) in the LETO ICCs from 72- to
120-hr (a 2.1-fold increase for 72-hr, a 3.3-fold
increase for both 96-hr and 120-hr, as compared
with the OLETF counterparts). Also, the gluca-
gon content (2-D) in the LETO ICCs showed
a 3.1-fold increase for 72-hr, a 4.0-fold increase
250
200
150
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2000
1500
48 72 96 120
D
48 72 96 120
Culture Time (hr)
FIGURE 2 Insulin and glucagon contents of ICCs. ICCs
from OLETF () and LETO (E) rats were measured for their
insulin and glucagon contents and normalized with their
DNA content. ICCs were cultured either in the presence of
5.5mM glucose (A and C) or 11.1mM glucose (B and D) for
48, 72, 96 and 120-hr, respectively. Data are presented as
mean 4- SEM from 6 experiments. *P < 0.05, **P < 0.01.
5.5 mM Glucose
12[A
1.2 ,_, 1.0
0.2
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FIGURE 3 fl-cell mass and non-fl-cell mass of ICCs. ICCs
from OLETF () and LETO ([]) rats cultured either in
5.5mM glucose (A and C) or 11.1mM glucose (B and D) for
48, 72, 96 and 120-hr, respectively, were calculated for fl-cell
mass and non-fl-cell mass as described in Materials and
Methods. Values are expressed as the 10% adjusted mean
percentage of fl-cell mass, or non-fl-cell mass profile area
relative to the ICCs mass profile area. The bars represent
SEM from 30-40 ICCs. **P < 0.01.DEFECTIVE MORPHORGENESIS OF FETAL ICCs 295
for 96-hr, and a 4.8-fold increase for 120-hr, as
compared with the OLETF counterparts. The
insulin and glucagon content data is consistent
with both fl-cell mass (3-A and 3-B) and non-fl-
cell mass (3-C and 3-D) from the LETO ICCs,
as a percentage of the total ICC mass. They are
significantly higher than those from the OLETF
counterparts. Furthermore, ICCs from the LETO
rats, cultured in 11.1mM glucose produced
a higher fl-cell mass than those of the culture
maintained in 5.5mM glucose.
Functional Maturation
of Cultured ICCs
We monitored the functional maturation of
cultured ICCs in response to glucose stimulation
in both OLETF and LETO rats (Fig. 4). It is ap-
parent that higher glucose culture (11.1mM)
facilitates the maturation process of fetal ICCs
suggesting that glucose is a potent stimulant for
L2 IA
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1"2IC
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0.4
48 72 96 120 48 72 96 120
Culture Time (hr)
FIGURE 4 Glucose-stimulated insulin secretion. The ICCs
from OLETF (A and B) and LETO (C and D) were cultured
either in the presence of 5.5mM glucose or 11.1mM glucose
for 48, 72, 96 and 120-hr, respectively. Insulin secretion in
response to glucose stimulation for 2 hr consecutive incuba-
tions in KRB buffer with 3.3mM glucose (m) for the first
hour and 27.7mM glucose ([-1) for the second hour. Insulin
secretion was normalized with DNA content. Data are pre-
sented as mean 4- SEM from 6 experiments. *P < 0.05,
**P < 0.01.
islet cell growth and differentiation. In LETO
rats, a significant insulin response was observed
in both 96 and 120-hr cultured ICCs. However,
the intensity of GSIS is much higher in the ICCs
cultured in 11.1mM glucose than in the 5.5mM
glucose culture. In contrast, GSIS in OLETF ICCs
failed to response except the ICCs cultured in
11.1mM glucose for 120-hr. Furthermore, the
level of insulin response in OLETF ICCs was
much lower than the LETO ICCs. The GSIS
indicated that glucose is a potent stimulant
to facilitate fetal islet cell maturation and the
OLETF ICCs failed to mature into functional
islets.
Expression of PDX-1 Protein
in Cultured ICCs
Comparing the expression level of the PDX-1
protein between OLETF ICCs and LETO ICCs
were shown in two culture conditions with 5.5
and 11.1mM glucose concentrations (Fig. 5).
PDX-1 was identified as a 46 kDa protein in ICCs
by Western blotting with PDX-1 antiserum.
[19]
In 11.1mM glucose culture (Fig. 5B), PDX-1
expression is significantly higher in normal
LETO ICCs than in OLETF ICCs. Particularly,
PDX-1 levels are higher at 48 and 72-hr culture,
which probably attribute to the expression of
PDX-1 in islet precursor cells. In a lower glucose
A B
"
48 72 96 120 48 72 96 120
Culture Time (hr)
FIGURE 5 PDX-1 protein expression in ICCs. Western blot
analysis of PDX-1 protein in the ICCs from OLETF (m) and
LETO ([) rats. The ICCs were cultured either in the presence
of 5.5mM glucose (A) or 11.1mM glucose (B) for 48, 72, 96
and 120-hr, respectively. Quantification of PDX-1 protein ex-
pression is shown by densitometer from 5 experiments.
*P < 0.05, *P < 0.01.296 M. ZHU et al.
concentration (5.5mM) (Fig. 5A), the matura-
tion of ICCs seems to be slower than 11.1mM
glucose. The expression level of PDX-1 only
increased after 120-hr culture in LETO ICCs,
which correlated well with the fl-cell mass
expansion. The OLETF ICCs expressed low lev-
els of PDX-1 throughout the 5.5mM glucose
culture.
DISCUSSION
The results presented here revealed defects
in the development of ICCs from the OLETF
rats, particularly in response to a high glucose
culture. This defect was demonstrated as a
growth retardation of the epithelial stratification
and poor development in both fl-cell and non-fl-
cell masses along with a parallel decline in
relevant islet hormone contents. The similar
abnormality in the fetal islets is generally ob-
served only in manifest diabetic mothers with
considerable hyperglycemia.
[21,22] However, the
cause of this defect is still unclear since we were
unable to detect any abnormalities in the non-
fasting blood glucose and plasma insulin level in
the OLETF rats during pregnancy. The incidence
of diabetes in the OLETF model is not homo-
genous and the incidence of diabetes between
the male and female rats are 86% and 0% at the
age over 23 weeks old,9 but the female OLETF
rats were shown to be potentially diabetic. [23,24]
The sexual dimorphism in the incidence of
diabetes mellitus in the OLETF model may
attribute to the ovarian hormone induced fl-cell
hypertrophy in female rats. 25 A characteristic
feature of male pancreas from diabetic OLETF
rat exhibits fibrotic connective tissue prolifera-
tion.
[11] In this study, we focus on fetal model of
OLETF rat pancreas development. Therefore, the
fetal ICCs from both sexes were used in this
study.
The morphological observations in the con-
trol rats, namely, the development of epithelial
stratification and duct-like structure, as well as
subsequent insulin-positive cell outgrowths
from the undifferentiated epithelial cell clusters
are consistent with islet neogenesis. 5-7 The
development of pancreatic islets appears to
be regulated by a variety of growth factors,
whereas glucose is a cardinal secretory and
mitogenic stimulus for pancreatic fl-cells both in
vitro and in vivo. [261 In control rats, 11.1mM
glucose produced higher fl-cell mass which was
accompanied by an increase in insulin content
and GSIS than observed for a culture in 5.5mM
glucose. It is conceivable that ICCs response
to high glucose concentration to undergo islet
cell differentiation in vitro.
[27] Furthermore, the
genetic background is of considerable impor-
tance in determining the proliferative response
of fl-cells to a change in environmental factor.
[28]
Therefore, we speculated that a limited potential
to undergo islet cell differentiation could be
attribute to a failure involved in the fetal model
of the OLETF rat, which might be genetically
predisposed.
It has been reported that rat fetal islets, up to
21-days, show an immature response to glucose-
stimulation [29,30] and these immature islets need
to undergo additional development during the
postnatal period to become mature islet cells.
[31]
Our data on the GSIS showed a progressive in-
crease ratio in response to glucose stimulation
as coupled with the development of fl-cell mass
in the ICCs from control LETO rats instead
of OLETF rats. Similarly, the changes in basal
insulin secretion and content of insulin were
also consistent with the changes in the propor-
tion of fl-cell mass within ICCs. It has been
reported that 11.1mM glucose resulted in sig-
nificant increase in the volume of fl-cell
mitochondria, secretory granules, and endoplas-
mic reticulum, which contribute to an increased
in insulin content andfurther increase in insulin
secretion rate.
[29] A delayed maturation of the
fetal fl-cells was also reported due to a lack
of glucose-stimulated fl-cell mass develop-
ment with low rate of fl-cell division ob-
served in the offspring of manifest diabetic ratDEFECTIVE MORPHORGENESIS OF FETAL ICCs 297
mothers.
[21] Both of the studies further support
that OLETF rats exhibit a defect involving
functional maturation coupled with morpholo-
gical development. Taken together, these
findings suggest that poor development
of functional fl-cell mass may be a result
of delayed maturation of fetal fl-cells in the
OLETF model rat.
PDX-1 has been shown to be essential for
pancreatic development. PDX-l-deficient mice
failed to develop a pancreas.
[13,15] During the
early development, PDX-1 was detected in most
pancreatic epithelial cells, and later only the islet
hormone-positive cells and a few ductal
cells were found to be positive for PDX-1 [32,33]
suggesting that PDX-1 is an important factor in
pancreatic development and in mature fl-cells.
In the present study, we revealed that the PDX-1
expression in the ICCs from OLETF rats was
significantly lower than that of the control rats.
Although we have little direct evidence to de-
monstrate PDX-1 expression in islet precursor
cells in this report, it is reasonable to speculate
that a failure of PDX-1 expression may hinder
the islet precursor cells from fully proliferating
and/or differentiating into mature endocrine
cells. In the presence of 11.1mM glucose, a
dramatic increase of PDX-1 in the ICCs from the
control rats in early culture period (48 to 72-hr)
was characterized by the occurrence of large
aggregated epithelial cells and the formation
of duct-like structures. This suggests that the
expression of PDX-1 may be required for the
early inductive event leading to the formation
of the pancreatic precursor cells and the sub-
sequent endocrine cell differentiation and de-
velopment in vitro. Another possible scenario
will be that the main defect of OLETF rats
is due to the inability of the mutant fl-cells to
proliferate. This decrease in fl-cell prolifera-
tion results in a lower number of fl-cells and,
consequently, to a decrease in expression of
PDX-1 per ICC. In order words, the ICCs have
low PDX-1 because they have fewer fl-cells.
Therefore, it would be interesting to further
analyze this defect during the embryonic devel-
opment in vivo.
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